neptra
bayer animal health gmbh - florfenicol, terbinafin-hidroklorid, mire furoate - otologicals, kortikoszteroidok, antiinfectives a kombináció - kutyák - a kezelés az akut kutya otitis externa, vagy akut exacerbációk visszatérő középfülgyulladás által okozott vegyes fertőzések, érzékeny baktérium érzékeny florfenicol (staphylococcus pseudintermedius), valamint a gombák érzékeny terbinafin (malassezia pachydermatis).
jayempi
nova laboratories ireland limited - azatioprin - graft visszautasítás - immunszuppresszánsok - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.
vyvgart
argenx - efgartigimod alfa - myasthenia gravis - immunszuppresszánsok - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.
spevigo
boehringer ingelheim international gmbh - spesolimab - pikkelysömör - immunszuppresszánsok - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.
lacosamide adroiq
extrovis eu ltd. - lakozamidot - epilepszia - antiepileptikumok, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
clindamycin hameln 150 mg/ml oldatos injekció vagy infúzió
hameln pharma gmbh - clindamycin phosphate -
britaject 10 mg/ml oldatos injekció vagy infúzió
britannia pharmaceuticals ltd - apomorfin-hidroklorid hemihidrát -
epirubicin accord 2 mg/ml oldatos injekció vagy infúzió
accord healthcare polska sp. z o.o. - epirubicin -
sayana 104 mg/0,65 ml szuszpenziós injekció
pfizer kft. - a számla -
irinotecan mylan pharma 20 mg/ml koncentrátum oldatos infúzióhoz
mylan s.a.s. - irinotecan -